Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | — |
the patient missed doses of Rabavert for post-exposure prophylaxis for a significant amount of time; The patient received first dose of RabAvert two days after was bitten by a dog; Case reference number US-BN-2025-001560 is a spontaneous case initially received from a pharmacist via Med communication (reference number: USBAV25-2235 (also reported as USBAV25-2315) on 17-Sep-2025 and concerns a 41-years-old male patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 22-Aug-2025, the patient was bitten by a dog. On 24-Aug-2025, the patient was presented to emergency room. On same date, the patient received the first dose of RabAvert vaccine along with its constituent parts: prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown, expiration date: unknown) at an unknown dose, intradermally, at an unknown site of administration for post-exposure prophylaxis (explicitly coded as 'inappropriate schedule of product administration'). As reported, the patient missed doses of Rabavert for post-exposure prophylaxis for a significant amount of time (explicitly coded as 'incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. No further information was provided.; Reporter's Comments: A spontaneous case concerning, a 41-year-old male was bitten by a dog 2 days before receiving his first RabAvert dose post-exposure prophylaxis. The vaccine was administered intradermally with unknown dose and site and coded as an inappropriate schedule. The patient missed subsequent doses, leading to an incomplete vaccination course. No adverse events were reported at the time. The events are considered listed per company convention. The outcome was unknown. The medical history and concomitant medications were not provided. The events are assessed as not related to suspect vaccine, but to human factor. The case is non-serious.; Sender's Comments: A spontaneous case concerning, a 41-year-old male was bitten by a dog 2 days before receiving his first RabAvert dose post-exposure prophylaxis. The vaccine was administered intradermally with unknown dose and site and coded as an inappropriate schedule. The patient missed subsequent doses, leading to an incomplete vaccination course. No adverse events were reported at the time. The events are considered listed per company convention. The outcome was unknown. The medical history and concomitant medications were not provided. The events are assessed as not related to suspect vaccine, but to human factor. The case is non-serious.
Comments: None.